评价Ficolin-3缺乏作为风险因素,在发展的风湿性心脏病的评估

Zahra Parker1, M Taariq Salie1, Kélin Engel1

  • 1Cape Heart Institute, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

BMC research notes
|May 9, 2025
PubMed
概括

风湿性心脏病 (RHD) 患者的菲科林-3水平较高,但特定的基因变异不能预测RHD风险或菲科林-3水平. 这些变异不是RHD易感性的可靠早期标志物.